A214 (Levetiracetam Extended Release 750 mg)
Pill with imprint A214 is Yellow, Elliptical/Oval and has been identified as Levetiracetam Extended Release 750 mg. It is supplied by Anchen Pharmaceuticals, Inc. .
Levetiracetam is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A214
Levetiracetam Extended Release
- Imprint
- A214
- Strength
- 750 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Anchen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 10370-0214 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hydroxypropyl cellulose,
magnesium stearate,
polyvinyl alcohol,
magnesium silicate,
polyethylene glycol,
titanium dioxide,
ferric oxide yellow,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "A214"
More about levetiracetam
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (381)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: pyrrolidine anticonvulsants
- Latest FDA Alerts (4)
Patient resources
- Drug Information
- Levetiracetam (Advanced Reading)
- Levetiracetam Intravenous (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Other brands
- Keppra, Keppra XR, Elepsia XR, Roweepra, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.